DCI Advisors Ltd (DCI.L) — Research Note
Executive summary
DCI Advisors is a Guernsey-incorporated, AIM-listed real-estate investment company in managed wind-down, holding a residual portfolio of early-stage, large-scale leisure resort developments in Greece (Kilada, Lavender Bay, Plaka Bay, Scorpio Bay), Cyprus (Apollo Heights, and until Feb-2025 Aristo Developers) and Croatia (Livka Bay) 2025-03 interim. The operating trajectory across the 5-year period is one of progressive realisation but repeated execution slippage: NAV/share has drifted from c.€0.19 (FY-19) through €0.16 (FY-20), €0.14 (FY-23) to €0.12 at Dec-24, the audit is qualified, the shares were suspended for ~7 months in 2024-25, and management has had to fund operations with high-coupon shareholder loans 2025-01 final results, 2025-03 interim. The single most important valuation point is that this is a NAV-discount realisation play: disclosed equity NAV is €108.1m (≈£91m / ~10p) but the realised price for Aristo in Feb-25 came in at a 30% discount to book, and remaining assets carry meaningful liquidity, legal and time-decay risks.
Fair value estimate
Methodology: Discount-to-NAV / sum-of-parts, anchored on disclosed equity NAV at 31 Dec 2024 with haircuts for realisation friction, going-concern risk and proven discounts on prior sales.
| Item | Amount |
|---|---|
| Disclosed equity NAV (31 Dec 2024) | €108.1m (~£91m) |
| Board's "real NAV" (zeroing -€19.3m Lavender liability) | €127.4m (~£107m) |
| Aristo sale (Feb-25) write-down vs book | €11.6m (-30% to carrying value) |
| Shareholder loans + shareholder-loan accrued interest | ~€5m at 12% p.a. |
| Period-end cash | €0.08m |
Reasoning: Aristo, the most "marketable" stake, realised at ~70% of carrying value. The Greek land bank (Lavender, Plaka, Scorpio) is largely undeveloped, with permitting and a live Church/State title dispute on Lavender. Livka Bay's signed June-2024 SPA at €22m collapsed because the buyer couldn't finance it. Kilada is mid-build with the JV partner and a third-party financier sitting ahead of DCI. Applying 25-40% blended haircuts to disclosed NAV plus deducting net liabilities, working-capital burn and realisation costs:
- Bear (40% NAV haircut): ~£55m → ~6p / share
- Central (30% haircut): ~£64m → ~7p / share
- Bull (use board's "real NAV", 20% haircut): ~£85m → ~9p / share
Fair value range: 6–9p per share, implied market cap £55–82m, midpoint ~7.5p / £68m.
Current market cap £41.2m (~4.6p): absolute upside ~+65% to midpoint (range +30% to +95%). The market is pricing a roughly 55% discount to disclosed NAV, which is plausible but, in my view, overly punitive given that the Aristo sale in Feb-25 confirms realisations are achievable.
Sector context
Sector classification (Real Estate) is correct in name only — DCI is not a yielding REIT but an AIM-listed run-off vehicle holding undeveloped/early-stage resort land, closer in profile to a small closed-end real-estate fund in liquidation. There are no clean listed peers; loose comparators include other AIM-listed Mediterranean land/resort vehicles in wind-down. The quality, growth and leverage profile is well below any conventional real-estate peer: no rental income, multi-year horizons, going-concern uncertainty, and complex litigation history.
Investment thesis (3 bullets)
- Discount to NAV with a recent live data point. Disclosed NAV is ~10p vs ~4.6p market price (55% discount); the Feb-25 Aristo sale at €31.1m provides a real realisation marker and €14.8m of cash inflow phased Feb/May/Aug 2025 that materially de-risks near-term liquidity 2025-03 interim.
- Capital return mechanism now in place. The December-2024 redomicile from BVI to Guernsey explicitly enabled compulsory share buybacks for surplus capital, and the 2025 AGM notice (May-2026) renews the buyback authority 2024-12 EGM, 2026-05 Notice of AGM. This is the structural step that converts asset sales into per-share value.
- Operating cost base materially reduced. 2024 opex fell 13% (20% ex-one-offs), legal costs down ~40%, and the previous Investment Manager (DCP) — historically the largest cost line at €3.6m fixed fee — was terminated in March 2023, with no fixed fee since. Lower cash burn lengthens the runway to realise remaining assets 2025-03 interim, 2025-01 final results.
Key risks (3 bullets)
- Qualified audit opinion and going-concern uncertainty. KPMG issued a qualified opinion on the FY-23 audited accounts on three separate matters (hotel-complex DCF inputs, DCI H2/Aristo valuation methodology departing from IFRS 13, and the €3m Investment-Manager receivable that should not have been recognised under IAS 37), plus a material-uncertainty going-concern paragraph 2025-01 final results, Auditors' Report. Disclosure quality is weak by listed-company standards.
- Lavender Bay legal overhang and land-creditor liability of €20.8m due Dec-2025. The Greek State disputes title to land DCI bought from the Greek Church; the accounts carry the position at –€19.3m and a €20.8m Lavender land-creditor balance falls due 31 Dec 2025. Negotiations with the Church are ongoing but unresolved 2025-03 interim.
- Execution / realisation risk on the remaining portfolio. Livka Bay's signed June-24 SPA at €22m did not complete (buyer couldn't fund); Kilada MOU expired; Apollo Heights is held up by SBA planning. The pattern across the 5-year filing set is one of repeated delays to disposals (not disclosed but inferred from successive interim/annual updates).
Operating leverage
DCI does not have operating leverage in the conventional sense — it generates negligible recurring revenue (€572k in 2024, mostly minor incidental income; the assets generate no rental yield). The cost base is largely fixed but small: 2024 professional fees €3.3m, directors' remuneration €0.5m, admin €1.6m, total opex ~€5.4m run-rate, dropping to €4.4m on a normalised basis after redomicile one-offs 2025-03 interim. Because there are no recurring revenues, "operating leverage" here is really terminal-value sensitivity to disposal prices: a 10% uplift in remaining-asset realisations (€100m of carrying value, ex-Aristo cash) drops c.€10m to equity (~24% of current market cap) before any leakage to opex, legal or tax. Conversely a 10% disposal shortfall takes ~25% off equity. So while there is no operating-margin story, there is meaningful realisation-price leverage — but with no fixed-cost-platform incremental contribution-margin dynamic.
Value-trap signals
- Repeated execution slippage: Livka Bay sale failed to complete; Kilada MOU expired; Apollo planning verdict delayed for years; Lavender legal dispute likely to take years to resolve in Greek courts.
- Declining NAV trajectory: Sterling NAV per share has fallen from ~17p (FY-19) to ~10p (Dec-24).
- Going-concern uncertainty + qualified audit opinion (already noted).
- Shareholder loans at 12% with rolling 12-month extensions — funding the cash burn at high coupons.
- Related-party complexity: Multiple director/shareholder loans (Discover Investment Co., Almitas, Nick Paris); legal disputes with the former Investment Manager and its associates (Zoniro, DCP) 2025-03 interim, notes 15.3, 32.
- Failed special resolution at Feb-2025 AGM (revised articles, 51.95% for vs 75% required) — signals significant shareholder dissatisfaction.
- Delayed accounts and 7-month share suspension (Jul-24 to Jan-25) — a clear governance red flag.
- NAV write-down on Aristo of €11.6m on actual sale — confirms book values exceed realisable values.
Earnings vs expectations
DCI does not publish forward earnings guidance and there is no meaningful published analyst consensus. The pattern visible across filings is one of repeatedly missed self-imposed disposal timelines rather than missed earnings: management commentary in 2021-22 contemplated "first distribution within 12 months", which is yet to occur in 2026; the Livka Bay sale was announced in June 2024 and remains uncompleted; the Apollo SBA planning verdict was "expected by end-2024" and is delayed. NAV has fallen versus its own prior-period base in 3 of the last 4 reported periods. This is firmly a "misses" pattern against management's own qualitative guidance, even though there are no formal consensus EPS comparisons to score.
Conviction
3 — moderate.
- Anchors: the Feb-2025 Aristo sale at €31.1m provides a live, externally validated realisation data point; the asset base is concrete (land, not goodwill); the disclosed NAV gives a defensible upper bound and the buyback mechanism is now in place.
- Caveats: qualified audit opinion, material going-concern uncertainty, contested Lavender title, and a track record of failed completions all widen the plausible range of outcomes considerably. A different valuer using a deeper haircut on Greek/Croatian land could land 30-40% lower than my central estimate.